294 related articles for article (PubMed ID: 15199491)
1. Congenital and acquired activated protein C resistance.
Nicolaes GA; Dahlbäck B
Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
3. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
Dahlbck B
J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
[TBL] [Abstract][Full Text] [Related]
4. Thrombophilia as a multigenic disease.
Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
[TBL] [Abstract][Full Text] [Related]
5. Resistance to activated protein C in women using oral contraceptives.
Spannagl M; Dick A; Assmann A; Heinemann L; Schramm W
Semin Thromb Hemost; 1998; 24(5):423-30. PubMed ID: 9834008
[TBL] [Abstract][Full Text] [Related]
6. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
7. Factor V and protein S as cofactors to activated protein C.
Dahlbäck B
Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
[TBL] [Abstract][Full Text] [Related]
8. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
9. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
10. Early days of APC resistance and FV Leiden.
Dahlbäck B
Hamostaseologie; 2008; 28(3):103-9. PubMed ID: 18521487
[TBL] [Abstract][Full Text] [Related]
11. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
Tans G; Nicolaes GA; Rosing J
Semin Hematol; 1997 Jul; 34(3):244-55. PubMed ID: 9241709
[TBL] [Abstract][Full Text] [Related]
12. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
Dahlbäck B
Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of phenotype resistance to activated protein C (APC resistance)].
Hudecek J; Ivanková J; Dobrotová M; Hybenová J; Pullmann R; Kubisz P
Vnitr Lek; 1999 Dec; 45(12):723-8. PubMed ID: 10951849
[TBL] [Abstract][Full Text] [Related]
14. Laboratory diagnosis of hereditary thrombophilia.
Michiels JJ; Hamulyák K
Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
[TBL] [Abstract][Full Text] [Related]
15. Mutation in blood coagulation factor V associated with resistance to activated protein C.
Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic APC resistance as a marker of hypercoagulability in primitive cerebral lymphoma.
De Lucia D; De Francesco F; Marotta R; Maisto G; Meo D; Sessa M; Misso M; Galante M; Russo T; Pignalosa O; Napolitano M; Papa ML; Niglio A; Di Micco P
Exp Oncol; 2005 Jun; 27(2):159-61. PubMed ID: 15995637
[TBL] [Abstract][Full Text] [Related]
18. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
Reitsma PH; van de Stolpe A
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
[TBL] [Abstract][Full Text] [Related]
19. Intraindividual consistency of the activated protein C resistance phenotype.
Tosetto A; Simioni M; Madeo D; Rodeghiero F
Br J Haematol; 2004 Aug; 126(3):405-9. PubMed ID: 15257714
[TBL] [Abstract][Full Text] [Related]
20. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
Dahlbäck B
Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]